Nurix legal chief sells shares after option exercise
Nurix Therapeutics Chief Legal Officer Christine Ring exercised stock options and sold the resulting shares in a pre-planned trade.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics Chief Legal Officer Christine Ring exercised stock options and sold the resulting shares in a pre-planned trade. On the reported date, she exercised options for 28,935 shares of common stock at strike prices of $8.72 and $7.26 per share and sold 28,935 shares in open-market transactions at a weighted average price of $20.0624 per share, pursuant to a Rule 10b5-1 trading plan. Following these transactions, the filing reports that she holds 13,579 shares of common stock directly and continues to hold employee stock options, including 134,398 options with a $8.72 exercise price expiring in 2034.
Insider Trade Summary 10b5-1
Exercise and Sale: 28,935 shares ($348K approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Ring Christine
Role
Chief Legal Officer
Sold
28,935 shs ($581K)
Approx. gross sale proceeds
$581K
Approx. exercise cost
$233K
Approx. pre-tax spread
$348K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 13,333 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) | 15,602 | $0.00 | $0.00 |
| Exercise | Common Stock | 13,333 | $7.26 | $97K |
| Exercise | Common Stock | 15,602 | $8.72 | $136K |
| Sale | Common Stock | 28,935 | $20.0624 | $581K |
Holdings After Transaction:
Employee Stock Option (right to buy) — 134,398 contracts (Direct);
Common Stock — 13,579 shares (Direct)
Footnotes (4)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2. Represents the weighted average sale price. The lowest price at which shares were sold was $20.00 and the highest price at which shares were sold was $20.40. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F3. The stock option vested as to 1/48 of the total shares monthly beginning February 18, 2020, until the option was fully vested on January 18, 2024.
- F4. The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027.
Key Figures
Shares sold: 28,935 shares
Weighted average sale price: $20.0624 per share
Options exercised: 28,935 shares
+4 more
7 metrics
Shares sold
28,935 shares
Open-market sale of common stock
Weighted average sale price
$20.0624 per share
Common stock sales on transaction date
Options exercised
28,935 shares
Total shares from option exercises (codes M)
Strike price 1
$8.72 per share
15,602-share employee stock option exercised
Strike price 2
$7.26 per share
13,333-share employee stock option exercised
Shares held after sale
13,579 shares
Direct common stock ownership following transactions
Remaining options
134,398 options
Employee stock options at $8.72 exercise price expiring 2034
Key Terms
Rule 10b5-1 trading plan, Employee Stock Option (right to buy, weighted average sale price, vested, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option (right to buy financial
"Employee Stock Option (right to buy) listed as a derivative security with underlying common stock."
weighted average sale price financial
"Represents the weighted average sale price. The lowest price at which shares were sold was $20.00 and the highest price was $20.40."
vested financial
"The stock option vested as to 1/48 of the total shares monthly beginning February 18, 2020, until the option was fully vested on January 18, 2024."
derivative security financial
"Transaction code description refers to Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Nurix Therapeutics (NRIX) report for Christine Ring?
Nurix Therapeutics reported that Chief Legal Officer Christine Ring exercised options for 28,935 shares of common stock and sold 28,935 shares in open-market transactions. These trades were executed under a previously adopted Rule 10b5-1 trading plan, indicating a pre-planned liquidity event.
What stock options did Christine Ring exercise in this Nurix Therapeutics (NRIX) Form 4?
Christine Ring exercised employee stock options covering 15,602 shares at a $8.72 exercise price and 13,333 shares at a $7.26 exercise price. These options had vested over time according to monthly vesting schedules that began in February 2020 and March 2024, respectively.
Was the Nurix Therapeutics (NRIX) insider stock sale by Christine Ring pre-planned?
Yes. A footnote explains that the stock sale was effected pursuant to a previously adopted Rule 10b5-1 trading plan. Such plans allow insiders to pre-schedule trades, helping separate routine portfolio management from discretionary trading decisions based on short-term market conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
